While many consider Deca-Durabolin a “mild” anabolic steroid in terms of side effects, the term “mild” is ambiguous and overly broad.
Nandrolone possesses both mild and harsh properties, with specific side effects unique to nandrolone itself.
These are rare with most other anabolic steroids, and it shares side effects and characteristics with its sister compound, Trenbolone.
Nandrolone is a 19-nor anabolic steroid, meaning the 19th carbon has been removed from testosterone, giving it a high binding affinity for progesterone receptors in the body.
This results in progestogenic activity, which is closely linked to estrogenic activity.
Nandrolone has moderate progestogenic activity, which can lead to side effects such as gynecomastia, water retention, and suppression of endogenous testosterone.
The progestin-related side effects, in particular, cause unique issues not commonly seen with other steroids, many of which resemble estrogenic side effects.
These characteristics of nandrolone require caution during use, making side effect management essential.
19-nor compounds (Nandrolone, Trenbolone) can increase prolactin levels in the body, leading to side effects such as lactation, erectile dysfunction, libido loss, and suppression/shutdown of endogenous testosterone production.
Interestingly, while progesterone itself suppresses prolactin production, nandrolone and trenbolone are not progesterone but rather chemically altered progestogenic-active steroids that can paradoxically increase prolactin.
Elevated prolactin levels can be managed with prolactin antagonists (e.g., Cabergoline, Pramipexole), and preventing elevated estrogen levels is also a crucial countermeasure.
Estrogen acts as a co-binding factor for prolactin receptors (PRLR), increasing prolactin sensitivity and potentially worsening the problem.
Therefore, managing estrogen levels can help reduce the risk of prolactin-related side effects.
The reason side effects from nandrolone and trenbolone manifest more severely in a high-estrogen environment is that when combined with aromatizable compounds (e.g., Testosterone), the resulting increase in estrogen exacerbates prolactin issues.
To prevent this, the key is to concurrently manage estrogen and use prolactin-suppressing drugs.
Estrogenic Side Effects
The estrogen-related side effects of Deca-Durabolin are relatively mild, as nandrolone has low estrogenic activity and binds weakly to the aromatase enzyme.
Nandrolone converts to estrogen at approximately 20% the rate of testosterone, a characteristic stemming from nandrolone being a progestin (a 19-nor compound).
While nandrolone can be converted to estrogen in the liver, it exhibits resistance to estrogen conversion in other tissues, such as adipose tissue.
This results in fewer estrogen-related side effects; however, because nandrolone is progestogenic, it can cause its own unique side effects, which are also linked to prolactin issues.
In conclusion, while Deca-Durabolin has a low rate of estrogen conversion, the potential progestogenic-related problems that can arise must be carefully considered.
Androgenic Side Effects
Deca-Durabolin has an androgenic rating of 37, which is significantly lower than testosterone’s androgenic strength (100), making it considered a suitable choice for those sensitive to androgenic side effects.
However, despite its low androgenic rating, the potential for side effects still exists, including oily skin and acne due to increased sebum secretion, body and facial hair growth, and the risk of triggering Male Pattern Baldness (MPB) in genetically predisposed individuals.
In women, Deca-Durabolin can cause virilization symptoms such as body hair growth, voice deepening, clitoral enlargement, and menstrual irregularities, although prudent use can reduce these risks.
However, the potential for side effects always exists, warranting caution.
HPTA and Endogenous Testosterone Production Side Effects
All anabolic steroids lead to the suppression or cessation of endogenous testosterone production, and Deca-Durabolin is no exception.
In the past, nandrolone was incorrectly believed to cause only ‘mild’ HPTA suppression, but in reality, it causes significant suppression.
Studies show that administration of 100mg per week reduced endogenous testosterone levels by 57%, while 300mg reduced them by up to 70%.
Nandrolone causes more severe HPTA suppression than most other steroids, attributable to its lack of a 19th carbon, which allows it to act as a progestin.
Progestogenic drugs like nandrolone and trenbolone, in particular, have a very potent HPTA suppression effect.
This suppressive effect can make the post-cycle recovery process difficult, making a PCT (Post Cycle Therapy) plan essential.
Hepatotoxicity Side Effects
Deca-Durabolin is not a C17-alpha alkylated oral anabolic steroid; therefore, there is no associated risk of hepatotoxicity with Deca-Durabolin.
Cardiovascular Side Effects
All anabolic steroids negatively impact cholesterol levels, decreasing HDL (good cholesterol) and increasing LDL (bad cholesterol), thereby elevating the risk of atherosclerosis.
The extent of these changes depends on the dosage, duration of use, and route of administration.
Notably, a study administering 600mg of Deca-Durabolin per week for 10 weeks showed a 26% decrease in HDL levels.
In a study comparing it to Testosterone Cypionate, Deca-Durabolin had a more negative impact on cholesterol, and recent studies confirm that nandrolone is more toxic to lipid metabolism than testosterone.
Cholesterol management is crucial, and strategies such as controlling dietary fat intake and incorporating cardiovascular exercise are recommended as essential for protecting cardiovascular health.
While Deca-Durabolin is effective, its unique side effects necessitate a cautious approach.
Prolactin management, cardiovascular health monitoring, and a thorough PCT are essential.
Drug use should aim for long-term health and sustainable growth, not just short-term results, and seeking guidance from experienced professionals is important.
